Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors
AssigneePfizer Inc.
InventorsWilliam H. Martin, Banavara L. Mylari
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsWilliam H. Martin, Banavara L. Mylari
Estimating the term…
This invention relates to novel sulfonyl pyridazinone compounds of the formula: wherein R1, R2, X, and Y are defined herein, which are useful as aldose reductase inhibitors in the treatment or prevention of certain complications arising from diabetes mellitus, pharmaceutical compositions comprising the sulfonyl pyridazinone, pharmaceutical compositions comprising a combination of the sulfonyl pyridazinone together with a second pharmaceutical agent, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds in combination with a second pharmaceutical agent and compounds useful as intermediates for preparing the sulfonyl pyridazinone compounds of this invention.
A compound of formula I:
A compound of formula XI:
A pharmaceutical composition comprising a compound of formula I:
A pharmaceutical composition comprising a first compound of formula I:
A therapeutic method comprising administering to a mammal in need of treatment or prevention of diabetic complications, an aldose reductase inhibiting amount of a compound of formula I:
A therapeutic method comprising administering to a mammal in need of treatment or prevention of diabetic complications an aldose reductase inhibiting amount of a first compound of formula I:
A kit comprising:
Dependencies are inferred from the claim text.